Cover Image
市場調查報告書

表觀遺傳學的全球市場 - 至2022年的預測:各產品 (套件、酵素、試劑、 NGS、質譜分析、PCR、生物資訊學)、用途、技術、終端用戶、地區

Epigenetics Market by Product (Kit, Enzymes, Reagent, NGS, Mass Spectrometer, PCR, Bioinformatics), Application (Oncology, Cardiology, Immunology), Technology (DNA Methylation, Histone Modification), End User (Academic, CRO) - Global Forecast to 2022

出版商 MarketsandMarkets 商品編碼 259906
出版日期 內容資訊 英文 227 Pages
訂單完成後即時交付
價格
Back to Top
表觀遺傳學的全球市場 - 至2022年的預測:各產品 (套件、酵素、試劑、 NGS、質譜分析、PCR、生物資訊學)、用途、技術、終端用戶、地區 Epigenetics Market by Product (Kit, Enzymes, Reagent, NGS, Mass Spectrometer, PCR, Bioinformatics), Application (Oncology, Cardiology, Immunology), Technology (DNA Methylation, Histone Modification), End User (Academic, CRO) - Global Forecast to 2022
出版日期: 2017年10月12日 內容資訊: 英文 227 Pages
簡介

全球表觀遺傳學市場,預計2017年達到了8億5,400萬美元。預計2022年擴大到16億570萬美元,2017年∼2022年以13.5%的年複合成長率成長。

本報告提供全球表觀遺傳學市場相關調查分析,市場概要,產業趨勢,各市場區隔的市場分析,競爭情形,主要企業等相關的系統性資訊。

第1章 簡介

第2章 調查手法

第3章 摘要整理

第4章 重要考察

  • 全球表觀遺傳學市場概要
  • 表觀遺傳學市場:已開發國家和開發中國家比較
  • 地區概要
  • 地區結構
  • 亞太地區市場:各技術
  • 表觀遺傳學套件市場規模:各類型

第5章 市場概要

  • 簡介
  • 市場區隔
  • 市場動態
    • 推動因素
    • 阻礙因素
    • 機會
    • 課題

第6章 表觀遺傳學市場:各產品

  • 簡介
  • 套件
  • 試劑
  • 酵素
  • 設備、消耗品

第7章 表觀遺傳學市場:各適用

  • 簡介
  • 腫瘤學
  • 代謝性疾病
  • 發生生物學
  • 免疫學
  • 循環系統疾病
  • 其他的用途

第8章 表觀遺傳學市場:各技術

  • 簡介
  • DNA甲基化
  • 組蛋白修飾
  • 其他

第9章 表觀遺傳學市場:各終端用戶

  • 簡介
  • 學術、研究機關
  • 製藥、生物科技企業
  • 臨床研究委外機構(CRO)

第10章 表觀遺傳學市場:各地區

  • 簡介
  • 北美
  • 歐洲
  • 亞洲
  • 南美
  • 中東、非洲

第11章 競爭情形

  • 簡介
  • 市場佔有率分析
  • 競爭情形與趨勢

第12章 企業簡介 (概要,產品與服務,策略、發展等)

  • LLUMINA
  • THERMO FISHER SCIENTIFIC
  • MERCK MILLIPORE
  • ABCAM
  • ACTIVE MOTIF
  • BIO-RAD
  • NEW ENGLAND BIOLABS
  • AGILENT
  • QIAGEN
  • ZYMO RESEARCH
  • PERKINELMER
  • DIAGENODE

第13章 附錄

圖表

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: BT 2775

"The Global Epigenetics Market Is Projected to Register a CAGR of 13.5% During the Forecast Period (2017-2022)."

The global epigenetics market is projected to reach USD 1,605.7 million by 2022 from USD 854.0 million in 2017, at a CAGR of 13.5% during the forecast period. The decreasing sequencing costs and time, increasing research activities, favorable funding scenario for epigenetics research, rising prevalence of cancer are the key factors driving market growth during the forecast period. On the other hand, the high cost of instruments is expected to restrain the growth of this market to a certain extent.

"Oncology Segment Dominated the Global Epigenetics Market, by Application, in 2016"

On the basis of application, the epigenetics market is segmented into oncology, metabolic diseases, developmental biology, immunology, cardiovascular diseases, and other applications (includes neurology, gynecology, and infectious diseases). In 2016, the oncology segment accounted for the major share of the global epigenetics market. The large share of this segment is attributed to the rising prevalence of cancer and the increasing number of research-related activities.

"Pharmaceutical and Biotechnology Companies to Register the Highest Growth Rate During the Forecast Period"

On the basis of end users, the epigenetics market is segmented into academic and research institutes, pharmaceutical and biotechnology companies, and contract research organizations (CROs). The pharmaceutical and biotechnology companies segment is expected to register the highest CAGR during the forecast period, owing to increasing research in the areas of genomics with a strong focus on personalized medicine.

"APAC to Witness the Highest Growth Rate During the Forecast Period"

The global epigenetics market is broadly segmented into five major regions, namely, North America, Europe, Asia Pacific (APAC), Latin America, and the Middle East & Africa. North America accounted for the largest share of the global epigenetics market in 2016, while Asia Pacific is projected to register the highest growth rate during the forecast period. Factors such as increasing R&D spending, favorable government initiatives, and rising focus of key market players on enhancing their presence in this region are supporting the growth of the epigenetics market in the Asia Pacific.

The breakup of primary participants has been mentioned below:

  • By Company Type - Tier 1: 35%, Tier 2-40% and Tier 3-25%
  • By Designation - C Level: 33%, Director Level: 41%, Others: 26%
  • By Region - North America: 35%, Europe: 30%, Asia Pacific: 21%, and RoW: 14%

The prominent players in the epigenetics market include Illumina (US), Thermo Fisher (US), Diagenode (Belgium), QIAGEN (Netherlands), Merck Millipore (US), Abcam (UK), Active Motif (US), New England Biolabs (US), Agilent (US), Zymo Research (US), PerkinElmer (US), and Bio-Rad (US).

Research Coverage:

The report aims at estimating the market size and future growth potential of the epigenetics market for different segments such as product, application, technology, end user, and region. The report also includes an in-depth competitive analysis of the key players in this market along with their company profiles, product offerings, recent developments, and market strategies.

Reasons to Buy the Report:

The report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn will help firms in garnering a greater market share. Firms purchasing the report could use any one or combination of the below-mentioned strategies for strengthening their market positions.

The report provides insights on the following pointers:

  • Market Penetration: Comprehensive information on the product portfolios offered by the top players in the epigenetics market
  • Product Development/Innovation: Detailed insights on the upcoming trends, research and development activities, and new product launches in the epigenetics market
  • Market Development: Comprehensive information about lucrative emerging markets, by product, application, technology, end user, and region
  • Market Diversification: Exhaustive information about new products, growing geographies, recent developments, and investments in the epigenetics market
  • Competitive Assessment: In-depth assessment of growth strategies, products, and manufacturing capabilities of leading players in the epigenetics market

TABLE OF CONTENTS

1. INTRODUCTION

  • 1.1. OBJECTIVES OF THE STUDY
  • 1.2. MARKET DEFINITION
  • 1.3. MARKET SCOPE
    • 1.3.1. MARKETS COVERED
    • 1.3.2. YEARS CONSIDERED FOR THE STUDY
  • 1.4. CURRENCY
  • 1.5. STAKEHOLDERS

2. RESEARCH METHODOLOGY

  • 2.1. RESEARCH APPROACH
    • 2.1.1. SECONDARY DATA
      • 2.1.1.1. Key data from secondary sources
    • 2.1.2. PRIMARY DATA
      • 2.1.2.1. Key Data from Primary Sources
      • 2.1.2.2. Key Industry Insights
  • 2.2. MARKET SIZE ESTIMATION
  • 2.3. MARKET BREAKDOWN AND DATA TRIANGULATION
  • 2.4. MARKET SHARE ESTIMATION
  • 2.5. ASSUMPTIONS FOR THE STUDY

3. EXECUTIVE SUMMARY

4. PREMIUM INSIGHTS

  • 4.1. EPIGENETICS MARKET: OVERVIEW
  • 4.2. EPIGENETICS MARKET: DEVELOPED VS DEVELOPING COUNTRIES
  • 4.3. GEOGRAPHIC SNAPSHOT: EPIGENETICS MARKET (2016)
  • 4.4. GEOGRAPHIC MIX: EPIGENETICS MARKET
  • 4.5. APAC: EPIGENETICS MARKET, BY TECHNOLOGY
  • 4.6. EPIGENETICS KITS MARKET SIZE, BY TYPE (2017 VS. 2022)

5. MARKET OVERVIEW

  • 5.1. INTRODUCTION
  • 5.2. KEY MARKET DYNAMICS
    • 5.2.1. MARKET DRIVERS
      • 5.2.1.1. Declining sequencing costs and time
      • 5.2.1.2. Increasing research activities and availability of government funding
      • 5.2.1.3. Rising cancer prevalence
    • 5.2.2. MARKET RESTRAINTS
      • 5.2.2.1. High cost of instruments
    • 5.2.3. MARKET OPPORTUNITIES
      • 5.2.3.1. High growth potential in emerging markets
      • 5.2.3.2. Growing applications of epigenetics in personalized medicine and targeted therapy
      • 5.2.3.3. Use of epigenetics in non-oncology applications
    • 5.2.4. MARKET CHALLENGES
      • 5.2.4.1. Dearth of trained professionals
      • 5.2.4.2. Concerns regarding the quality of antibodies

6. EPIGENETICS MARKET, BY PRODUCT

  • 6.1. INTRODUCTION
  • 6.2. KITS
    • 6.2.1. CHIP-SEQ KITS
    • 6.2.2. BISULFITE CONVERSION KITS
    • 6.2.3. WHOLE-GENOME AMPLIFICATION KITS
    • 6.2.4. 5-HMC AND 5-MC ANALYSIS KITS
    • 6.2.5. RNA SEQUENCING KITS
    • 6.2.6. OTHER EPIGENETICS KITS
  • 6.3. REAGENTS
    • 6.3.1. ANTIBODIES
    • 6.3.2. MAGNETIC BEADS
    • 6.3.3. HISTONES
    • 6.3.4. BUFFERS
    • 6.3.5. PRIMERS
    • 6.3.6. OTHER EPIGENETICS REAGENTS
  • 6.4. ENZYMES
    • 6.4.1. DNA-MODIFYING ENZYMES
    • 6.4.2. PROTEIN-MODIFYING ENZYMES
    • 6.4.3. RNA-MODIFYING ENZYMES
  • 6.5. INSTRUMENTS AND CONSUMABLES
    • 6.5.1. NEXT-GENERATION SEQUENCERS
    • 6.5.2. QPCR INSTRUMENTS
    • 6.5.3. MASS SPECTROMETERS
    • 6.5.4. SONICATORS
    • 6.5.5. OTHER INSTRUMENTS AND CONSUMABLES
  • 6.6. BIOINFORMATICS TOOLS

7. EPIGENETICS MARKET, BY APPLICATION

  • 7.1. INTRODUCTION
  • 7.2. ONCOLOGY
  • 7.3. METABOLIC DISEASES
  • 7.4. DEVELOPMENTAL BIOLOGY
  • 7.5. IMMUNOLOGY
  • 7.6. CARDIOVASCULAR DISEASES
  • 7.7. OTHER APPLICATIONS

8. EPIGENETICS MARKET, BY TECHNOLOGY

  • 8.1. INTRODUCTION
  • 8.2. DNA METHYLATION
  • 8.3. HISTONE MODIFICATION
  • 8.4. OTHER TECHNOLOGIES

9. EPIGENETICS MARKET, BY END USER

  • 9.1. INTRODUCTION
  • 9.2. ACADEMIC AND RESEARCH INSTITUTES
  • 9.3. PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES
  • 9.4. CONTRACT RESEARCH ORGANIZATIONS

10. EPIGENETICS MARKET, BY REGION

  • 10.1. INTRODUCTION
  • 10.2. NORTH AMERICA
    • 10.2.1. US
    • 10.2.2. CANADA
  • 10.3. EUROPE
    • 10.3.1. GERMANY
    • 10.3.2. UK
    • 10.3.3. FRANCE
    • 10.3.4. ITALY
    • 10.3.5. SPAIN
    • 10.3.6. REST OF EUROPE
  • 10.4. ASIA PACIFIC
    • 10.4.1. JAPAN
    • 10.4.2. CHINA
    • 10.4.3. INDIA
    • 10.4.4. REST OF ASIA PACIFIC
  • 10.5. LATIN AMERICA
  • 10.6. MIDDLE EAST AND AFRICA

11. COMPETITIVE LANDSCAPE

  • 11.1. INTRODUCTION
  • 11.2. MARKET SHARE ANALYSIS (2016)
  • 11.3. COMPETITIVE SITUATIONS & TRENDS
    • 11.3.1. PRODUCT LAUNCHES & ENHANCEMENT
    • 11.3.2. ACQUISITIONS
    • 11.3.3. AGREEMENTS, COLLABORATIONS, AND PARTNERSHIPS
    • 11.3.4. EXPANSIONS
    • 11.3.5. OTHER DEVELOPMENTS

12. COMPANY PROFILES (Overview, Products Offered, Product Offering Scorecard, Business Strategy Scorecard, Recent Developments)*

  • 12.1. ILLUMINA
  • 12.2. THERMO FISHER SCIENTIFIC
  • 12.3. MERCK MILLIPORE
  • 12.4. ABCAM
  • 12.5. ACTIVE MOTIF
  • 12.6. BIO-RAD
  • 12.7. NEW ENGLAND BIOLABS
  • 12.8. AGILENT
  • 12.9. QIAGEN
  • 12.10. ZYMO RESEARCH
  • 12.11. PERKINELMER
  • 12.12. DIAGENODE

*Details on MarketsandMarkets view, Overview, Products Offered, Product Offering Scorecard, Business Strategy Scorecard, and Recent Developments might not be captured in case of unlisted companies.

13. APPENDIX

  • 13.1. DISCUSSION GUIDE
  • 13.2. KNOWLEDGE STORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 13.3. INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE
  • 13.4. AVAILABLE CUSTOMIZATIONS
  • 13.5. RELATED REPORTS
  • 13.6. AUTHOR DETAILS

LIST OF TABLES

  • TABLE 1: GLOBAL EPIGENETICS MARKET, BY PRODUCT, 2015-2022 (USD MILLION)
  • TABLE 2: GLOBAL EPIGENETICS KITS MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 3: GLOBAL EPIGENETICS KITS MARKET, BY COUNTRY/REGION, 2015-2022 (USD MILLION)
  • TABLE 4: GLOBAL CHIP-SEQ KITS MARKET, BY COUNTRY/REGION, 2015-2022 (USD MILLION)
  • TABLE 5: GLOBAL BISULFITE CONVERSION KITS MARKET, BY COUNTRY/REGION, 2015-2022 (USD MILLION)
  • TABLE 6: GLOBAL WHOLE-GENOME AMPLIFICATION KITS MARKET, BY COUNTRY/REGION, 2015-2022 (USD MILLION)
  • TABLE 7: GLOBAL 5-HMC AND 5-MC ANALYSIS KITS MARKET, BY COUNTRY/REGION, 2015-2022 (USD MILLION)
  • TABLE 8: GLOBAL RNA SEQUENCING KITS MARKET, BY COUNTRY/REGION, 2015-2022 (USD MILLION)
  • TABLE 9: GLOBAL OTHER EPIGENETICS KITS MARKET, BY COUNTRY/REGION, 2015-2022 (USD MILLION)
  • TABLE 10: GLOBAL EPIGENETICS REAGENTS MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 11: GLOBAL EPIGENETICS REAGENTS MARKET, BY COUNTRY/REGION, 2015-2022 (USD MILLION)
  • TABLE 12: GLOBAL ANTIBODIES MARKET, BY COUNTRY/REGION, 2015-2022 (USD MILLION)
  • TABLE 13: GLOBAL MAGNETIC BEADS MARKET, BY COUNTRY/REGION, 2015-2022 (USD MILLION)
  • TABLE 14: GLOBAL HISTONES MARKET, BY COUNTRY/REGION, 2015-2021 (USD MILLION)
  • TABLE 15: GLOBAL BUFFERS MARKET, BY COUNTRY/REGION, 2015-2022 (USD MILLION)
  • TABLE 16: GLOBAL PRIMERS MARKET, BY COUNTRY/REGION, 2015-2022 (USD MILLION)
  • TABLE 17: GLOBAL OTHER EPIGENETICS REAGENTS MARKET, BY COUNTRY/REGION, 2015-2022 (USD MILLION)
  • TABLE 18: GLOBAL EPIGENETICS ENZYMES MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 19: GLOBAL EPIGENETICS ENZYMES MARKET, BY COUNTRY/REGION, 2015-2022 (USD MILLION)
  • TABLE 20: GLOBAL DNA-MODIFYING ENZYMES MARKET, BY COUNTRY/REGION, 2015-2022 (USD MILLION)
  • TABLE 21: GLOBAL PROTEIN-MODIFYING ENZYMES MARKET, BY COUNTRY/REGION, 2015-2022 (USD MILLION)
  • TABLE 22: GLOBAL RNA-MODIFYING ENZYMES MARKET, BY COUNTRY/REGION, 2015-2022 (USD MILLION)
  • TABLE 23: GLOBAL EPIGENETICS INSTRUMENTS AND CONSUMABLES MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 24: GLOBAL EPIGENETICS INSTRUMENTS AND CONSUMABLES MARKET, BY COUNTRY/REGION, 2015-2022 (USD MILLION)
  • TABLE 25: GLOBAL NEXT-GENERATION SEQUENCERS MARKET, BY COUNTRY/REGION, 2015-2022 (USD MILLION)
  • TABLE 26: GLOBAL QPCR INSTRUMENTS MARKET, BY COUNTRY/REGION, 2015-2022 (USD MILLION)
  • TABLE 27: GLOBAL MASS SPECTROMETERS MARKET, BY COUNTRY/REGION, 2015-2022 (USD MILLION)
  • TABLE 28: GLOBAL SONICATORS MARKET, BY COUNTRY/REGION, 2015-2022 (USD MILLION)
  • TABLE 29: GLOBAL OTHER INSTRUMENTS AND CONSUMABLES MARKET, BY COUNTRY/REGION, 2015-2022 (USD MILLION)
  • TABLE 30: GLOBAL BIOINFORMATICS TOOLS MARKET, BY COUNTRY/REGION, 2015-2022 (USD MILLION)
  • TABLE 31: GLOBAL EPIGENETICS MARKET, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 32: EPIGENOME-TARGETING CANCER DRUGS APPROVED OR IN CLINICAL TRIALS
  • TABLE 33: GLOBAL EPIGENETICS MARKET FOR ONCOLOGY, BY COUNTRY/REGION, 2015-2022 (USD MILLION)
  • TABLE 34: GLOBAL EPIGENETICS MARKET FOR METABOLIC DISEASES, BY COUNTRY/REGION, 2015-2022 (USD MILLION)
  • TABLE 35: GLOBAL EPIGENETICS MARKET FOR DEVELOPMENTAL BIOLOGY, BY COUNTRY/REGION, 2015-2022 (USD MILLION)
  • TABLE 36: GLOBAL EPIGENETICS MARKET FOR IMMUNOLOGY, BY COUNTRY/REGION, 2015-2022 (USD MILLION)
  • TABLE 37: GLOBAL EPIGENETICS MARKET FOR CARDIOVASCULAR DISEASES, BY COUNTRY/REGION, 2015-2022 (USD MILLION)
  • TABLE 38: GLOBAL EPIGENETICS MARKET FOR OTHER APPLICATIONS, BY COUNTRY/REGION, 2015-2022 (USD MILLION)
  • TABLE 39: GLOBAL EPIGENETICS MARKET, BY TECHNOLOGY, 2015-2022 (USD MILLION)
  • TABLE 40: GLOBAL DNA METHYLATION MARKET, BY COUNTRY/REGION, 2015-2022 (USD MILLION)
  • TABLE 41: GLOBAL HISTONE MODIFICATION MARKET, BY COUNTRY/REGION, 2015-2022 (USD MILLION)
  • TABLE 42: GLOBAL OTHER TECHNOLOGIES MARKET, BY COUNTRY/REGION, 2015-2022 (USD MILLION)
  • TABLE 43: GLOBAL EPIGENETICS MARKET, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 44: GLOBAL EPIGENETICS MARKET FOR ACADEMIC AND RESEARCH INSTITUTES, BY COUNTRY/REGION, 2015-2022 (USD MILLION)
  • TABLE 45: GLOBAL EPIGENETICS MARKET FOR PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY COUNTRY/REGION, 2015-2022 (USD MILLION)
  • TABLE 46: GLOBAL EPIGENETICS MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY/REGION, 2015-2022 (USD MILLION)
  • TABLE 47: EPIGENETICS MARKET, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 48: NORTH AMERICA: EPIGENETICS MARKET, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 49: NORTH AMERICA: EPIGENETICS MARKET, BY PRODUCT, 2015-2022 (USD MILLION)
  • TABLE 50: NORTH AMERICA: EPIGENETICS KITS MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 51: NORTH AMERICA: EPIGENETICS REAGENTS MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 52: NORTH AMERICA: EPIGENETICS ENZYMES MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 53: NORTH AMERICA: EPIGENETICS INSTRUMENTS AND CONSUMABLES MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 54: NORTH AMERICA: EPIGENETICS MARKET, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 55: NORTH AMERICA: EPIGENETICS MARKET, BY TECHNOLOGY, 2015-2022 (USD MILLION)
  • TABLE 56: NORTH AMERICA: EPIGENETICS MARKET, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 57: US: EPIGENETICS MARKET, BY PRODUCT, 2015-2022 (USD MILLION)
  • TABLE 58: US: EPIGENETICS KITS MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 59: US: EPIGENETICS REAGENTS MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 60: US: EPIGENETICS ENZYMES MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 61: US: EPIGENETICS INSTRUMENTS AND CONSUMABLES MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 62: US: EPIGENETICS MARKET, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 63: US: EPIGENETICS MARKET, BY TECHNOLOGY, 2015-2022 (USD MILLION)
  • TABLE 64: US: EPIGENETICS MARKET, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 65: CANADA: EPIGENETICS MARKET, BY PRODUCT, 2015-2022 (USD MILLION)
  • TABLE 66: CANADA: EPIGENETICS KITS MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 67: CANADA: EPIGENETICS REAGENTS MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 68: CANADA: EPIGENETICS ENZYMES MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 69: CANADA: EPIGENETICS INSTRUMENTS AND CONSUMABLES MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 70: CANADA: EPIGENETICS MARKET, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 71: CANADA: EPIGENETICS MARKET, BY TECHNOLOGY, 2015-2022 (USD MILLION)
  • TABLE 72: CANADA: EPIGENETICS MARKET, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 73: EUROPE: EPIGENETICS MARKET, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 74: EUROPE: EPIGENETICS MARKET, BY PRODUCT, 2015-2022 (USD MILLION)
  • TABLE 75: EUROPE: EPIGENETICS KITS MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 76: EUROPE: EPIGENETICS REAGENTS MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 77: EUROPE: EPIGENETICS ENZYMES MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 78: EUROPE: EPIGENETICS INSTRUMENTS AND CONSUMABLES MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 79: EUROPE: EPIGENETICS MARKET, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 80: EUROPE: EPIGENETICS MARKET, BY TECHNOLOGY, 2015-2022 (USD MILLION)
  • TABLE 81: EUROPE: EPIGENETICS MARKET, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 82: GERMANY: EPIGENETICS MARKET, BY PRODUCT, 2015-2022 (USD MILLION)
  • TABLE 83: GERMANY: EPIGENETICS KITS MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 84: GERMANY: EPIGENETICS REAGENTS MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 85: GERMANY: EPIGENETICS ENZYMES MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 86: GERMANY: EPIGENETICS INSTRUMENTS AND CONSUMABLES MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 87: GERMANY: EPIGENETICS MARKET, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 88: GERMANY: EPIGENETICS MARKET, BY TECHNOLOGY, 2015-2022 (USD MILLION)
  • TABLE 89: GERMANY: EPIGENETICS MARKET, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 90: UK: EPIGENETICS MARKET, BY PRODUCT, 2015-2022 (USD MILLION)
  • TABLE 91: UK: EPIGENETICS KITS MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 92: UK: EPIGENETICS REAGENTS MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 93: UK: EPIGENETICS ENZYMES MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 94: UK: EPIGENETICS INSTRUMENTS AND CONSUMABLES MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 95: UK: EPIGENETICS MARKET, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 96: UK: EPIGENETICS MARKET, BY TECHNOLOGY, 2015-2022 (USD MILLION)
  • TABLE 97: UK: EPIGENETICS MARKET, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 98: FRANCE: EPIGENETICS MARKET, BY PRODUCT, 2015-2022 (USD MILLION)
  • TABLE 99: FRANCE: EPIGENETICS KITS MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 100: FRANCE: EPIGENETICS REAGENTS MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 101: FRANCE: EPIGENETICS ENZYMES MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 102: FRANCE: EPIGENETICS INSTRUMENTS AND CONSUMABLES MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 103: FRANCE: EPIGENETICS MARKET, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 104: FRANCE: EPIGENETICS MARKET, BY TECHNOLOGY, 2015-2022 (USD MILLION)
  • TABLE 105: FRANCE: EPIGENETICS MARKET, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 106: ITALY: EPIGENETICS MARKET, BY PRODUCT, 2015-2022 (USD MILLION)
  • TABLE 107: ITALY: EPIGENETICS KITS MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 108: ITALY: EPIGENETICS REAGENTS MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 109: ITALY: EPIGENETICS ENZYMES MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 110: ITALY: EPIGENETICS INSTRUMENTS AND CONSUMABLES MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 111: ITALY: EPIGENETICS MARKET, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 112: ITALY: EPIGENETICS MARKET, BY TECHNOLOGY, 2015-2022 (USD MILLION)
  • TABLE 113: ITALY: EPIGENETICS MARKET, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 114: SPAIN: EPIGENETICS MARKET, BY PRODUCT, 2015-2022 (USD MILLION)
  • TABLE 115: SPAIN: EPIGENETICS KITS MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 116: SPAIN: EPIGENETICS REAGENTS MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 117: SPAIN: EPIGENETICS ENZYMES MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 118: SPAIN: EPIGENETICS INSTRUMENTS AND CONSUMABLES MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 119: SPAIN: EPIGENETICS MARKET, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 120: SPAIN: EPIGENETICS MARKET, BY TECHNOLOGY, 2015-2022 (USD MILLION)
  • TABLE 121: SPAIN: EPIGENETICS MARKET, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 122: ROE: EPIGENETICS MARKET, BY PRODUCT, 2015-2022 (USD MILLION)
  • TABLE 123: ROE: EPIGENETICS KITS MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 124: ROE: EPIGENETICS REAGENTS MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 125: ROE: EPIGENETICS ENZYMES MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 126: ROE: EPIGENETICS INSTRUMENTS AND CONSUMABLES MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 127: ROE: EPIGENETICS MARKET, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 128: ROE: EPIGENETICS MARKET, BY TECHNOLOGY, 2015-2022 (USD MILLION)
  • TABLE 129: ROE: EPIGENETICS MARKET, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 130: ASIA PACIFIC: EPIGENETICS MARKET, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 131: ASIA PACIFIC: EPIGENETICS MARKET, BY PRODUCT, 2015-2022 (USD MILLION)
  • TABLE 132: ASIA PACIFIC: EPIGENETICS KITS MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 133: ASIA PACIFIC: EPIGENETICS REAGENTS MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 134: ASIA PACIFIC: EPIGENETICS ENZYMES MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 135: ASIA PACIFIC: EPIGENETICS INSTRUMENTS AND CONSUMABLES MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 136: ASIA PACIFIC: EPIGENETICS MARKET, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 137: ASIA PACIFIC: EPIGENETICS MARKET, BY TECHNOLOGY, 2015-2022 (USD MILLION)
  • TABLE 138: ASIA PACIFIC: EPIGENETICS MARKET, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 139: JAPAN: EPIGENETICS MARKET, BY PRODUCT, 2015-2022 (USD MILLION)
  • TABLE 140: JAPAN: EPIGENETICS KITS MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 141: JAPAN: EPIGENETICS REAGENTS MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 142: JAPAN: EPIGENETICS ENZYMES MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 143: JAPAN: EPIGENETICS INSTRUMENTS AND CONSUMABLES MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 144: JAPAN: EPIGENETICS MARKET, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 145: JAPAN: EPIGENETICS MARKET, BY TECHNOLOGY, 2015-2022 (USD MILLION)
  • TABLE 146: JAPAN: EPIGENETICS MARKET, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 147: CHINA: EPIGENETICS MARKET, BY PRODUCT, 2015-2022 (USD MILLION)
  • TABLE 148: CHINA: EPIGENETICS KITS MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 149: CHINA: EPIGENETICS REAGENTS MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 150: CHINA: EPIGENETICS ENZYMES MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 151: CHINA: EPIGENETICS INSTRUMENTS AND CONSUMABLES MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 152: CHINA: EPIGENETICS MARKET, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 153: CHINA: EPIGENETICS MARKET, BY TECHNOLOGY, 2015-2022 (USD MILLION)
  • TABLE 154: CHINA: EPIGENETICS MARKET, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 155: INDIA: EPIGENETICS MARKET, BY PRODUCT, 2015-2022 (USD MILLION)
  • TABLE 156: INDIA: EPIGENETICS KITS MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 157: INDIA: EPIGENETICS REAGENTS MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 158: INDIA: EPIGENETICS ENZYMES MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 159: INDIA: EPIGENETICS INSTRUMENTS AND CONSUMABLES MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 160: INDIA: EPIGENETICS MARKET, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 161: INDIA: EPIGENETICS MARKET, BY TECHNOLOGY, 2015-2022 (USD MILLION)
  • TABLE 162: INDIA: EPIGENETICS MARKET, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 163: ROAPAC: EPIGENETICS MARKET, BY PRODUCT, 2015-2022 (USD MILLION)
  • TABLE 164: ROAPAC: EPIGENETICS KITS MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 165: ROAPAC: EPIGENETICS REAGENTS MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 166: ROAPAC: EPIGENETICS ENZYMES MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 167: ROAPAC: EPIGENETICS INSTRUMENTS AND CONSUMABLES MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 168: ROAPAC: EPIGENETICS MARKET, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 169: ROAPAC: EPIGENETICS MARKET, BY TECHNOLOGY, 2015-2022 (USD MILLION)
  • TABLE 170: ROAPAC: EPIGENETICS MARKET, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 171: LATIN AMERICA: EPIGENETICS MARKET, BY PRODUCT, 2015-2022 (USD MILLION)
  • TABLE 172: LATIN AMERICA: EPIGENETICS KITS MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 173: LATIN AMERICA: EPIGENETICS REAGENTS MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 174: LATIN AMERICA: EPIGENETICS ENZYMES MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 175: LATIN AMERICA: EPIGENETICS INSTRUMENTS AND CONSUMABLES MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 176: LATIN AMERICA: EPIGENETICS MARKET, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 177: LATIN AMERICA: EPIGENETICS MARKET, BY TECHNOLOGY, 2015-2022 (USD MILLION)
  • TABLE 178: LATIN AMERICA: EPIGENETICS MARKET, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 179: MIDDLE EAST AND AFRICA: EPIGENETICS MARKET, BY PRODUCT, 2015-2022 (USD MILLION)
  • TABLE 180: MIDDLE EAST AND AFRICA: EPIGENETICS KITS MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 181: MIDDLE EAST AND AFRICA: EPIGENETICS REAGENTS MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 182: MIDDLE EAST AND AFRICA: EPIGENETICS ENZYMES MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 183: MIDDLE EAST AND AFRICA: EPIGENETICS INSTRUMENTS AND CONSUMABLES MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 184: MIDDLE EAST AND AFRICA: EPIGENETICS MARKET, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 185: MIDDLE EAST AND AFRICA: EPIGENETICS MARKET, BY TECHNOLOGY, 2015-2022 (USD MILLION)
  • TABLE 186: MIDDLE EAST AND AFRICA: EPIGENETICS MARKET, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 187: NEW PRODUCT LAUNCHES AND ENHANCEMENTS, 2014-2017
  • TABLE 188: ACQUISITIONS, 2014-2017
  • TABLE 189: AGREEMENTS, COLLABORATIONS AND PARTNERSHIPS, 2014-2017
  • TABLE 190: EXPANSIONS, 2014-2017
  • TABLE 191: OTHER DEVELOPMENTS, 2014-2017

LIST OF FIGURES

  • FIGURE 1: RESEARCH DESIGN
  • FIGURE 2: BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
  • FIGURE 3: BOTTOM-UP APPROACH
  • FIGURE 4: TOP-DOWN APPROACH
  • FIGURE 5: DATA TRIANGULATION METHODOLOGY
  • FIGURE 6: GLOBAL EPIGENETICS MARKET, BY PRODUCT, 2017 VS. 2022 (USD BILLION)
  • FIGURE 7: GLOBAL EPIGENETICS MARKET, BY APPLICATION, 2017 VS. 2022 (USD BILLION)
  • FIGURE 8: GLOBAL EPIGENETICS MARKET, BY TECHNOLOGY, 2017 VS. 2022 (USD BILLION)
  • FIGURE 9: GLOBAL EPIGENETICS MARKET, BY END USER, 2017 VS. 2022 (USD BILLION)
  • FIGURE 10: GEOGRAPHIC SNAPSHOT: EPIGENETICS MARKET
  • FIGURE 11: DECLINING SEQUENCING COSTS, INCREASING RESEARCH ACTIVITIES, AND RISING CANCER PREVALENCE-KEY MARKET DRIVERS
  • FIGURE 12: CHINA TO REGISTER HIGHEST GROWTH IN THE FORECAST PERIOD
  • FIGURE 13: US ACCOUNTED FOR THE LARGEST SHARE OF THE EPIGENETICS MARKET IN 2016
  • FIGURE 14: NORTH AMERICA TO DOMINATE THE EPIGENETICS MARKET DURING THE FORECAST PERIOD
  • FIGURE 15: DNA METHYLATION TECHNOLOGY COMMANDED THE LARGEST SHARE OF THE APAC EPIGENETICS MARKET IN 2016
  • FIGURE 16: CHIP-SEQ KITS DOMINATES THE EPIGENETICS KITS MARKET IN 2017 AND 2022
  • FIGURE 17: EPIGENETICS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
  • FIGURE 18: SEQUENCING COST PER GENOME, 2001-2015 (USD MILLION)
  • FIGURE 19: KITS SEGMENT TO COMMAND THE LARGEST SHARE OF THE EPIGENETICS MARKET IN 2017
  • FIGURE 20: ONCOLOGY APPLICATION SEGMENT TO COMMAND THE LARGEST SHARE OF THE EPIGENETICS MARKET IN 2017
  • FIGURE 21: DNA METHYLATION SEGMENT TO COMMAND THE LARGEST SHARE OF THE EPIGENETICS MARKET IN 2017
  • FIGURE 22: ACADEMIC AND RESEARCH INSTITUTES END USER SEGMENT TO ACCOUNT FOR THE LARGEST SHARE OF THE EPIGENETICS MARKET IN 2017
  • FIGURE 23: EPIGENETICS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
  • FIGURE 24: NORTH AMERICA: EPIGENETICS MARKET SNAPSHOT
  • FIGURE 25: ASIA PACIFIC: EPIGENETICS MARKET SNAPSHOT
  • FIGURE 26: GLOBAL EPIGENETICS MARKET SHARE ANALYSIS, BY KEY PLAYER, 2016
  • FIGURE 27: ILLUMINA: COMPANY SNAPSHOT (2016)
  • FIGURE 28: THERMO FISHER SCIENTIFIC: COMPANY SNAPSHOT (2016)
  • FIGURE 29: MERCK MILLIPORE: COMPANY SNAPSHOT (2016)
  • FIGURE 30: ABCAM: COMPANY SNAPSHOT (2016)
  • FIGURE 31: BIO-RAD: COMPANY SNAPSHOT (2016)
  • FIGURE 32: AGILENT: COMPANY SNAPSHOT (2016)
  • FIGURE 33: QIAGEN: COMPANY SNAPSHOT (2016)
  • FIGURE 34: PERKINELMER: COMPANY SNAPSHOT (2016)
Back to Top